Neuropeptides as Possible Targets in Sleep Disorders: Special Emphasis on Hypocretin-Deficient Narcolepsy

E-ISSN： 1996-3181|6|1|45-62

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.1, 2007-02, pp. : 45-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep- Wakefulness Cycle and Energy Homeostasis

Current Neuropharmacology, Vol. 7, Iss. 1, 2009-03 ,pp. : 50-59

Bentham Science Publishers

Access to resources Recommend Favorite

The hypocretin/orexin receptor: therapeutic prospective in sleep disorders

By Nishino Seiji

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 11, 2007-11 ,pp. : 1785-1797

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin

By Wiesenfeld-Hallin Z. Xu X.-J.

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 49-59

Elsevier

Access to resources Recommend Favorite

Editorial [Hot Topic: The Sleep-Wake Cycle, the Hypocretin/Orexin System and Narcolepsy: Advances from Preclinical Research to Treatment (Guest Editors: Oscar Arias-Carrion and Margaret Bradbury)]

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 4, 2009-08 ,pp. : 232-234

Bentham Science Publishers

Access to resources Recommend Favorite